Syndromes and complications of interferon therapy
- 1 January 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 19 (1) , 61-66
Abstract
Interferons are used to treat a variety of medical conditions. They are integral players in immunity and a number of immune-mediated complications can arise during interferon therapy. We have reviewed the occurrence of these complications, and the mechanisms behind them. Case reports and follow-up studies of large cohorts of patients on interferon therapy have confirmed that immune-mediated complications are uncommon but can occur in a number of different organ systems. IFNalpha production is induced by specific autoantibody-nuclear antigen immune complexes, and has a key role in the development and maintenance of autoimmunity in systemic lupus erythematosus. Interferon therapy can precipitate immune-mediated abnormalities de novo or can exacerbate an existing autoimmune tendency. This is manifest in the rise in titre of existing antibodies and in the development of clinical disease in patients with preexisting antibodies. Type I interferons have a key role in the development of systemic lupus erythematosus.Keywords
This publication has 50 references indexed in Scilit:
- Long-term follow-up of hepatitis B carrier children treated with interferon and prednisoloneJournal of Medical Virology, 2006
- The clinical and physiological spectrum of interferon‐alpha induced thyroiditisHepatology, 2006
- The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon‐alpha and ribavirin combination therapyJournal of Viral Hepatitis, 2006
- Is interferon‐alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case–control studyAlimentary Pharmacology & Therapeutics, 2005
- Innate and Acquired Immune System in Patients Developing Interferon-α-Related Autoimmune Thyroiditis: A Prospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2005
- Long‐term outcome of interferon‐α‐induced autoimmune thyroid disorders in chronic hepatitis CLiver International, 2005
- Thyroid autoimmunity and dysfunction associated with type I interferon therapyClinical and Experimental Medicine, 2004
- Non--Organ-Specific Autoantibodies in Children with Chronic Hepatitis C: Clinical Significance and Impact on Interferon TreatmentClinical Infectious Diseases, 2003
- Side effects of high-dose interferon therapy for chronic hepatitis CJournal of Hepatology, 1996
- Induction of Antinuclear Antibody after Interferon Therapy in Patients with Type-C Chronic Hepatitis: Its Relation to the Efficacy of TherapyScandinavian Journal of Gastroenterology, 1996